scholarly journals Prevalence and associated factors of polypharmacy among adult Saudi medical outpatients at a tertiary care center

2013 ◽  
Vol 20 (3) ◽  
pp. 162 ◽  
Author(s):  
SalihBin Salih ◽  
Huda Durihim ◽  
Hind Almodaimegh ◽  
Muhammad Yousuf ◽  
Hani Tamim
Author(s):  
L.A. Navia-López ◽  
J.F. Cadena-León ◽  
K.R. Ignorosa-Arellano ◽  
E.M. Toro-Monjaraz ◽  
F. Zárate-Mondragón ◽  
...  

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Bianca Senger Vasconcelos Barros ◽  
Fernanda Cruz Monteiro ◽  
Carlos Terra ◽  
Marilia Brito Gomes

Abstract Background Data on non-alcoholic fatty liver disease (NAFLD) in individuals with type 1 diabetes (T1D) is controversial and so far, there are no published data on the Brazilian population. We investigated the prevalence of steatosis and hepatic fibrosis in a population with T1D from a tertiary care center in Brazil and its associated factors. Methods Ninety-five participants with T1D, aged 39 ± 13 years, with disease duration of 21 ± 9 years, being 55 (57.9%) females, from a university hospital in Rio de Janeiro, were screened for NAFLD with hepatic ultrasound (US) and transient elastography (TE). Results Prevalence of steatosis was, respectively, 12.6% and 16.8% when US and TE were used for diagnosis of NAFLD. Fibrosis was present in 8.4% of participants. A total of 31.6% of participants had at least one of the hepatic exams altered, which was associated with higher body mass index, waist circumference, hip circumference and waist-to-hip ratio,, presence of metabolic syndrome and higher triglycerides levels, even within the normal range. After multivariate analysis, presence of steatosis was only associated with metabolic syndrome and its component, triglycerides. Conclusion In our study, prevalence of NAFLD in ultrasound approximates the one found with TE. Fibrosis was not frequent. Screening should be reserved for participants with T1D and metabolic syndrome, as this was the main factor associated with NAFLD. Triglycerides levels were the only component of metabolic syndrome associated with steatosis. Further studies are necessary to determine the best screening strategy for NAFLD in individuals with T1D. Also, predisposing factors for development in fibrosis in T1D should be further explored in prospective studies.


Contraception ◽  
2013 ◽  
Vol 88 (3) ◽  
pp. 470
Author(s):  
J. Kuperman ◽  
K. Brown ◽  
N. Edison ◽  
C. Westhoff ◽  
P. Castano

2019 ◽  
Vol 12 (2) ◽  
pp. 31-35
Author(s):  
Padma Chandavathu ◽  
◽  
Akurathi Krishna Rao ◽  

Sign in / Sign up

Export Citation Format

Share Document